Price:

Daniel Ek targets US medical system with $499 AI scans

Sep 29, 2026Summary from 1 podcast.
  • Daniel Ek is bringing $499 AI-powered health scans to the US market.
  • Insurers refuse preventative funding because patients switch jobs every three years.
  • Neko Health found serious undiagnosed conditions in one percent of scanned patients.

American healthcare burns 18 percent of national GDP on treating illness after it strikes.

Speaking on All-In, Spotify co-founder Daniel Ek pointed to a structural misalignment in how medicine is financed. Because the average American worker switches jobs every two to three years, insurance carriers face no incentive to fund early intervention. A preventative treatment with a decade-long payback window offers zero financial return to an insurer whose policyholder will transfer to a competitor long before disease manifests.

Ek founded Neko Health in 2018 to bypass insurance gatekeepers with direct-to-consumer data collection. For $499, the clinic conducts a one-hour assessment combining 53 blood biomarkers, cardiovascular testing, grip strength evaluation, and 6,000 high-resolution camera images indexing every millimeter of a patient's skin.

The visual dataset solves a basic human limitation. The average adult carries roughly 950 moles across their body, making manual tracking across annual doctor visits nearly impossible. Neko uses artificial intelligence models to track microscopic changes and flag anomalous growth patterns year-over-year, handing those visual flags to clinicians to detect early melanomas and unseen cardiovascular risks.

Early results across Europe show the model finding hidden illness at scale. In 100,000 patient scans conducted in Sweden and the United Kingdom, Neko identified severe, previously undiagnosed conditions in roughly one percent of participants. Ek noted that members starting with the poorest baseline health showed the most dramatic clinical improvements after receiving their baseline data.

The broader strategy mirrors Ek's playbook at Spotify: build a fine-tuned technical pipeline that lowers unit costs until market behavior shifts. Beyond medical diagnostics, Ek argued on All-In that regulators targeting artificial intelligence are focusing on the wrong target by trying to restrict open-source code.

Drawing parallels to cold-war supercomputer controls, Ek argued that meaningful AI regulation belongs at the datacenter level rather than inside consumer software. A developer running open weights on a desktop cannot trigger catastrophic risks, whereas 100,000-GPU compute clusters demand real infrastructure governance. Spotify itself pairs fine-tuned open models with frontier systems to run personal recommendations without blowing out processing budgets.

The fix for broken systems comes down to hardware economics.

Source Intelligence

- Deep dive into what was said in the episodes

Daniel Ek: Life After Spotify, Broken Healthcare Incentives, Catching Disease Early & AI's Potential • Sep 28

  • Daniel Ek co-founded Neko Health in 2018, spending five years developing its diagnostic technology before launching in Sweden in 2023. The startup mimics the Spotify playbook by expanding to the United Kingdom and the United States.
  • Daniel Ek points to structural flaws in US healthcare, where the nation spends 18% of its GDP on care, including hundreds of billions of dollars on heart disease alone, yet continues to experience declining population health outcomes.
  • Neko Health charges $499 for a vertically integrated, one-hour preventative scan that measures 53 blood markers. It also captures over 6,000 high-resolution body images to index skin anomalies, and evaluates cardiovascular health and grip strength.
  • From 100,000 scans, Neko Health's longitudinal data reveals that 1% of members have a serious, previously undiagnosed disease. Daniel Ek notes that members with the poorest baseline health show the most significant lifestyle and clinical improvements.
  • Because the average person has 950 moles, manual clinical reviews are prone to missing anomalies. Neko Health uses artificial intelligence to analyze and flag potential dermatological risks across thousands of data points, which human clinicians then review.
  • Daniel Ek argues that tying health insurance to employment creates a short-term incentive structure. Because average job tenure is only two to three years, insurers resist investing in preventative care that has a 10 to 20-year payback period.
Also discussed on this episode: (4)

Big Tech (1)

  • Daniel Ek transitioned to executive chairman of Spotify this year, a platform he started in 2006. The music service has scaled to over 700 million active users and 300 million premium subscribers.

History (1)

  • Sweden's early adoption of high-speed broadband in the early 2000s fueled rampant music piracy, causing the domestic music industry to lose 80% of its revenues. This environment facilitated Spotify's early licensing negotiations with desperate record labels.

Open Source (1)

  • Daniel Ek supports open-source artificial intelligence but suggests that compute scale will dictate commercial defensibility. Running models on 100,000 GPUs offers massive capability advantages over open-source models running on consumer hardware.

Startups (1)

  • Before Spotify, Daniel Ek served as interim chief technology officer for the Swedish startup Stardoll. He rebuilt the website to reduce page load times from four minutes to under a second, prompting a traffic spike and Sequoia Capital investment.